| LBCTR2023015204 | NCT05628389 | Phone Enabled Implementation of Cessation Support | Phone Enabled Implementation of Cessation Support | Interventional | Pending | 21/11/2022 |
| LBCTR2023065392 | CEHDF2110 | Comparison of the impact of two NEurofeedback EEG protocols on the perception and threshold of experimental pain in healthy subjects | Physiological and validation study in healthy subjects of the effect of two Neurofeedback protocols on acute pain - clinical trial. | Interventional | Recruiting | 29/06/2023 |
| LBCTR2019121361 | HD2305 | Preoperative Chlorhexidine Gluconate Bathing Could Prevent Post-obstetric and gynecologic Surgical-site Infections: A Pilot for a Randomized Controlled Trial | Preoperative Chlorhexidine Gluconate Bathing Could Prevent Post-obstetric and gynecologic Surgical-site Infections: A Pilot for a Randomized Controlled Trial | Interventional | Pending | 24/12/2019 |
| LBCTR2025035706 | MO41552 | RANDOMIZED, OPEN LABEL, MULTICENTER, PHASE III STUDY OF ENTRECTINIB VERSUS CRIZOTINIB IN PATIENTS WITH LOCALLY-ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER HARBORING ROS1 GENE REARRANGEMENTS WITH AND WITHOUT CENTRAL NERVOUS SYSTEM METASTASES | RANDOMIZED, OPEN LABEL, MULTICENTER, PHASE III STUDY OF ENTRECTINIB VERSUS CRIZOTINIB IN PATIENTS WITH LOCALLY-ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER HARBORING ROS1 GENE REARRANGEMENTS WITH AND WITHOUT CENTRAL NERVOUS SYSTEM METASTASES | Interventional | Recruiting | 09/12/2024 |
| LBCTR2019010169 | LPI-JOR-LEB-KSA-TUN-2017-01 | Randomized, Open-Label, Phase II, Multicenter, Multi-Country Study to Evaluate Safety and Efficacy of Dasatinib 50 mg in First-Line Treatment of Early Chronic Phase Chronic Myeloid Leukemia | Randomized, Open-Label, Phase II, Multicenter, Multi-Country Study to Evaluate Safety and Efficacy of Dasatinib 50 mg in First-Line Treatment of Early Chronic Phase Chronic Myeloid Leukemia | Interventional | Recruiting | 24/10/2018 |
| LBCTR2018090151 | Rasha123 | Rasha 123 | Rasha 123 | Observational | Complete | 15/09/2018 |
| LBCTR2022035014 | TRACE 2020-9591 | Real-World Evidence Study on AbeMaciclib Treatment Patterns and Effectiveness in Patients with HR+/HER2- Locally Advanced or Metastatic BReAst CancEr in Kuwait and Lebanon. | Real-World Evidence Study on AbeMaciclib Treatment Patterns and Effectiveness in Patients with HR+/HER2- Locally Advanced or Metastatic BReAst CancEr in Kuwait and Lebanon. | Observational | Recruiting | 16/03/2022 |
| LBCTR2018120174 | BIO-2017-0422 | Short-Course Radiation Followed by mFOLFOX-6 Plus COMPOUND 2055269 for Locally-Advanced Rectal Adenocarcinoma | Short-Course Radiation Followed by mFOLFOX-6 Plus COMPOUND 2055269 for Locally-advanced Rectal Adenocarcinoma | Interventional | Recruiting | 28/12/2018 |
| LBCTR2019030190 | CBYL719C2301 | A phase III randomized double-blind, placebo controlled study of alpelisib in combination with fulvestrant for men and postmenopausal women with hormone receptor positive, HER2-negative advanced breast cancer which progressed on or after aromatase inhibitor treatment | SOLAR-1: A phase III randomized double-blind, placebo controlled study of alpelisib in combination with fulvestrant for men and postmenopausal women with hormone receptor positive, HER2-negative advanced breast cancer which progressed on or after aromatase inhibitor treatment | Interventional | Complete | 07/02/2019 |
| LBCTR2020074524 | BIO-2018-0009 | Liver diseases in Lebanon | Spectrum of Liver diseases in Lebanon: a retrospective cohort study | Observational | Complete | 17/07/2020 |